The difference in obstructive sleep apnoea symptoms between patients with obstructive and inflammatory diseases Source: Eur Respir J 2005; 26: Suppl. 49, 65s Year: 2005
The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006
Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018
Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012
Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007
The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006
Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
The difference in obstructive sleep apnoea symptoms between patients with pulmonary and extra pulmonary inflammatory diseases Source: Eur Respir J 2006; 28: Suppl. 50, 644s Year: 2006
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002
Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
The association of chronic obstructive pulmonary disease and sleep apnea syndrome (overlap syndrome) Source: Eur Respir J 2002; 20: Suppl. 38, 495s Year: 2002
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? Source: Eur Respir J 2012; 39: 1547-1549 Year: 2012
Prevalence of obstructive airway disease in patients with obstructive sleep apnea Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
The use of systemic corticosteroids in children with obstructive sleep apnea syndrome Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019
Obstructive sleep apnoea and COPD Source: Eur Respir Mon 2013; 59: 135-143 Year: 2013